MassBio CEO warns 2025 may be biotech's toughest year amid China and NIH challenges
read at Endpoints ↗Negative
Massachusetts is widely regarded as the epicenter of biotech because of its world‑class research institutions and vibrant startup ecosystem.
MassBio CEO Kendalle Burlin O’Connell said 2025 will probably be the most challenging year she can remember, pointing to hurdles in China and with the NIH.
The remarks underscore growing uncertainty for the region’s biotech sector and may prompt caution among investors and companies.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “MassBio report details challenges spanning China, NIH”
read at Endpoints ↗89 words · retrieved Aug 26
comments(0)
5-min edit window · permanent after that